Evaluations of Molecular Diagnostic Biomarkers


Assessment of Molecular Diagnostic Biomarkers A biomarker is a trademark that is even-handedly evaluated and surveyed as a pointer of common biologic methodology, pathogenic techniques, or pharmacologic responses to an accommodating mediation. It used to perceive or avow the proximity of an infirmity or condition of premium or to recognize individuals with a subtype of the ailment.



 


  • PCR enzyme-linked immunosorbent assay
  • Antibodies or proteins
  • Microbial assays
  • Analytical and clinical evaluations
  • Screening

Related Conference of Evaluations of Molecular Diagnostic Biomarkers

June 25-26, 2024

13th World Congress on Chromatography

Toronto, Canada
August 22-23, 2024

16th International Conference on Clinical Chemistry

Berlin, Germany
October 14-15, 2024

4th International Conference on Analytical Chemistry

Barcelona, Spain
November 13-14, 2024

5th World Expo on Biopolymers and Bioplastics

Dubai, UAE
December 12-13, 2024

23rd World Congress on Nutrition and Food Chemistry

Rome, Italy
December 18-19, 2024

4th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands

Evaluations of Molecular Diagnostic Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in